Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Outcomes and Patterns of Failure After Definitive Prostate-Directed Radiotherapy and Metastasis-Directed Therapy in Patients With Synchronous De Novo Prostate Cancer and Up to 10 Metastases: An Ambispective Multicenter Real-World Evidence Registry

NCT07686016 is registered in ClinicalTrials.gov with Affidea Nu-med Center of Oncological DIagnostics and Therapy as lead sponsor.

NCT NCT07686016
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07686016 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Outcomes and Patterns of Failure After Definitive Prostate-Directed Radiotherapy and Metastasis-Directed Therapy in Patients With Synchronous De Novo Prostate Cancer and Up to 10 Metastases: An Ambispective Multicenter Real-World Evidence Registry
Lead sponsor
Affidea Nu-med Center of Oncological DIagnostics and Therapy
Phase
Observational
Overall status
Recruiting
Start date
June 26, 2026
Completion date
December 30, 2029
Enrollment
700 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic prostate cancer, oligometastatic prostate cancer, prostate cancer, synchronous oligometastatic prostate cancer